Revolution Medicines, Inc. (RVMD) Misses Q2 EPS by 9c, beats revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: RVMD) | Delayed: 186.99 -0.7 (0.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $187.69 | 52 Week High | $ | |||
| Open | $187.59 | 52 Week Low | $ | |||
| Day High | $189.52 | P/E | N/A | |||
| Day Low | $183.61 | EPS | $ | |||
| Volume | 1,720,159 | |||||
